{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:32:57Z","timestamp":1791059577995,"version":"4.1.0"},"reference-count":166,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T00:00:00Z","timestamp":1346976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The filoviruses marburg- and ebolaviruses can cause severe hemorrhagic fever (HF) in humans and nonhuman primates. Because many cases have occurred in geographical areas lacking a medical research infrastructure, most studies of the pathogenesis of filoviral HF, and all efforts to develop drugs and vaccines, have been carried out in biocontainment laboratories in non-endemic countries, using nonhuman primates (NHPs), guinea pigs and mice as animal models. NHPs appear to closely mirror filoviral HF in humans (based on limited clinical data), but only small numbers may be used in carefully regulated experiments; much research is therefore done in rodents. Because of their availability in large numbers and the existence of a wealth of reagents for biochemical and immunological testing, mice have become the preferred small animal model for filovirus research. Since the first experiments following the initial 1967 marburgvirus outbreak, wild-type or mouse-adapted viruses have been tested in immunocompetent or immunodeficient mice. In this paper, we review how these types of studies have been used to investigate the pathogenesis of filoviral disease, identify immune responses to infection and evaluate antiviral drugs and vaccines. We also discuss the strengths and weaknesses of murine models for filovirus research, and identify important questions for further study.<\/jats:p>","DOI":"10.3390\/v4091477","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T11:21:14Z","timestamp":1347016874000},"page":"1477-1508","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Mouse Models for Filovirus Infections"],"prefix":"10.3390","volume":"4","author":[{"given":"Steven B.","family":"Bradfute","sequence":"first","affiliation":[{"name":"Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM 87131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Warfield","sequence":"additional","affiliation":[{"name":"Vaccine Development, Integrated Biotherapeutics, Inc., Gaithersburg, MD 20878, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Bray","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2012,9,7]]},"reference":[{"key":"ref_1","first-page":"13","article-title":"Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies","volume":"20","author":"Kuhn","year":"2008","journal-title":"Arch. Virol. Suppl."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-010-0814-x","article-title":"Proposal for a revised taxonomy of the family Filoviridae: Classification, names of taxa and viruses, and virus abbreviations","volume":"155","author":"Kuhn","year":"2010","journal-title":"Arch. Virol."},{"key":"ref_3","unstructured":"Kuhn, J.H., Becker, S., Ebihara, H., Geisbert, T.W., Jahrling, P.B., Kawaoka, Y., Netesov, S.V., Nichol, S.T., Peters, C.J., Volchkov, V.E., and Ksiazek, T.G. (2011). Virus Taxonomy\u2014Ninth Report of the International Committee on Taxonomy of Viruses, Elsevier\/Academic Press."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00705-012-1299-6","article-title":"Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012)","volume":"157","author":"Adams","year":"2012","journal-title":"Arch. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/bsp.2011.0051","article-title":"Evaluation of perceived threat differences posed by filovirus variants","volume":"9","author":"Kuhn","year":"2011","journal-title":"Biosecur. Bioterror."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0035-9203(78)90058-5","article-title":"Ebola haemorrhagic fever: Experimental infection of monkeys","volume":"72","author":"Bowen","year":"1978","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF01249960","article-title":"A strain of \u201cMarburg virus\u201d (Rhabdovirus simiae) pathogenic to mice","volume":"32","author":"Hofmann","year":"1970","journal-title":"Arch. Gesamte Virusforsch."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(77)92002-5","article-title":"Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire","volume":"1","author":"Pattyn","year":"1977","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/379724","article-title":"Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes\/macrophages is a key event","volume":"188","author":"Geisbert","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jmv.1890040309","article-title":"Ebola virus virulence for newborn mice","volume":"4","author":"Jacob","year":"1979","journal-title":"J. Med. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(77)92001-3","article-title":"Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent","volume":"1","author":"Bowen","year":"1977","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/jcm.13.4.791-793.1981","article-title":"Plaque assay for Ebola virus","volume":"13","author":"Moe","year":"1981","journal-title":"J. Clin. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1099\/0022-1317-82-6-1365","article-title":"The role of the Type I interferon response in the resistance of mice to filovirus infection","volume":"82","author":"Bray","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1128\/JVI.00126-09","article-title":"Development and characterization of a mouse model for Marburg hemorrhagic fever","volume":"83","author":"Warfield","year":"2009","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.ppat.0020073","article-title":"Molecular determinants of Ebola virus virulence in mice","volume":"2","author":"Ebihara","year":"2006","journal-title":"PLoS Pathog."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/v3091634","article-title":"Filoviral immune evasion mechanisms","volume":"3","author":"Ramanan","year":"2011","journal-title":"Viruses"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jcpa.2001.0502","article-title":"Pathogenesis of experimental Ebola Zaire virus infection in BALB\/c mice","volume":"125","author":"Gibb","year":"2001","journal-title":"J. Comp. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.4049\/jimmunol.180.6.4058","article-title":"Functional CD8+ T cell responses in lethal Ebola virus infection","volume":"180","author":"Bradfute","year":"2008","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/labinvest.3780021","article-title":"Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses","volume":"80","author":"Geisbert","year":"2000","journal-title":"Lab. Invest."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1086\/520602","article-title":"Lymphocyte death in a mouse model of Ebola virus infection","volume":"196","author":"Bradfute","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_23","unstructured":"(1978). Ebola haemorrhagic fever in Zaire, 1976. Bull. World Health Organ., 56, 271\u2013293."},{"key":"ref_24","unstructured":"(1978). Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO\/International Study Team. Bull. World Health Organ., 56, 247\u2013270."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"Baize","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1086\/514283","article-title":"Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection","volume":"179","author":"Villinger","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"pii:e837","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/v3070982","article-title":"Correlates of immunity to filovirus infection","volume":"3","author":"Bradfute","year":"2011","journal-title":"Viruses"},{"key":"ref_30","unstructured":"Bradfute, S.B., Greiner, D.L., Shultz, L.D., and Bavari, S. Humanized mice as models for ebolavirus infection, Unpublished work, USAMRIID, Fort Detrick, MD, USA. manuscript in preparation, 2012."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1086\/520608","article-title":"Marburg virus Angola infection of rhesus macaques: Pathogenesis and treatment with recombinant nematode anticoagulant protein c2","volume":"196","author":"Geisbert","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S986","DOI":"10.1093\/infdis\/jir335","article-title":"Filovirus infection of STAT-1 knockout mice","volume":"204","author":"Raymond","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1743-422X-4-108","article-title":"Development of a model for marburgvirus based on severe-combined immunodeficiency mice","volume":"4","author":"Warfield","year":"2007","journal-title":"Virol. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","article-title":"Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: A study in rhesus monkeys","volume":"362","author":"Geisbert","year":"2003","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1086\/520598","article-title":"Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever","volume":"196","author":"Hensley","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4049\/jimmunol.0901231","article-title":"Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis","volume":"184","author":"Bradfute","year":"2010","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/vim.2004.17.390","article-title":"Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic fever in cynomolgus macaques","volume":"17","author":"Reed","year":"2004","journal-title":"Viral Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/JVI.02372-10","article-title":"Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process","volume":"85","author":"Lofts","year":"2011","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1099\/jmm.0.036210-0","article-title":"Lethality and pathogenesis of airborne infection with filoviruses in A129 alpha\/beta -\/- interferon receptor-deficient mice","volume":"61","author":"Lever","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S968","DOI":"10.1093\/infdis\/jir330","article-title":"Assessment of rodents as animal models for Reston ebolavirus","volume":"204","author":"Munster","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(02)00018-9","article-title":"3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice","volume":"55","author":"Bray","year":"2002","journal-title":"Antivir. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","article-title":"DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation","volume":"8","author":"Miranda","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0042-6822(03)00233-2","article-title":"Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection","volume":"312","author":"Mahanty","year":"2003","journal-title":"Virology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/JVI.78.2.958-967.2004","article-title":"Persistent infection with ebola virus under conditions of partial immunity","volume":"78","author":"Gupta","year":"2004","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1743-422X-6-132","article-title":"Discovery of common marburgvirus protective epitopes in a BALB\/c mouse model","volume":"6","author":"Kalina","year":"2009","journal-title":"Virol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1086\/520588","article-title":"Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: Identification of alleles associated with fatal and nonfatal disease outcomes","volume":"196","author":"Sanchez","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3201\/eid1302.060963","article-title":"Prevention of immune cell apoptosis as a potential therapeutic strategy for severe infections","volume":"13","author":"Parrino","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during Ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily","volume":"80","author":"Hensley","year":"2002","journal-title":"Immunol. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2007.02.017","article-title":"Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro","volume":"364","author":"Gupta","year":"2007","journal-title":"Virology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","article-title":"Pathogenesis of Ebola hemorrhagic fever in primate models: Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1009657006550","article-title":"Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?","volume":"5","author":"Baize","year":"2000","journal-title":"Apoptosis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","article-title":"Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: Cellular responses, virus load, and nitric oxide levels","volume":"78","author":"Sanchez","year":"2004","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2009.06.001","article-title":"Development of a broad-spectrum antiviral with activity against Ebola virus","volume":"83","author":"Aman","year":"2009","journal-title":"Antivir. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.20032141","article-title":"Role of natural killer cells in innate protection against lethal ebola virus infection","volume":"200","author":"Warfield","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein","volume":"75","author":"Wilson","year":"2001","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"Warfield","year":"2005","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1086\/520612","article-title":"Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents","volume":"196","author":"Warfield","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1086\/520605","article-title":"Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent","volume":"196","author":"Warfield","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.ppat.0020001","article-title":"Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers","volume":"2","author":"Warfield","year":"2006","journal-title":"PLoS Pathog."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.4049\/jimmunol.174.7.4198","article-title":"CD8-mediated protection against Ebola virus infection is perforin dependent","volume":"174","author":"Gupta","year":"2005","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"12874","DOI":"10.1074\/jbc.M809633200","article-title":"Reduced expression of CD45 protein tyrosine phosphatase provides protection against anthrax pathogenesis","volume":"284","author":"Panchal","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.chom.2009.07.003","article-title":"Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection","volume":"6","author":"Panchal","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4161\/hv.7.6.15398","article-title":"Filovirus vaccines","volume":"7","author":"Bradfute","year":"2011","journal-title":"Hum. Vaccin."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/viro.1998.9176","article-title":"DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge","volume":"246","author":"Vanderzanden","year":"1998","journal-title":"Virology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0264-410X(01)00353-X","article-title":"Marburg virus vaccines, comparing classical and new approaches","volume":"20","author":"Hevey","year":"2002","journal-title":"Vaccine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.20011500","article-title":"Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses","volume":"195","author":"Bavari","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-8244(03)00273-6","article-title":"Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein","volume":"40","author":"Swenson","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"Warfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","article-title":"Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections","volume":"23","author":"Swenson","year":"2005","journal-title":"Vaccine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"Warfield","year":"2005","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/CVI.00431-07","article-title":"Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections","volume":"15","author":"Swenson","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.vaccine.2011.01.113","article-title":"Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice","volume":"29","author":"Konduru","year":"2011","journal-title":"Vaccine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0264-410X(01)00353-X","article-title":"Marburg virus vaccines: Comparing classical and new approaches","volume":"20","author":"Hevey","year":"2001","journal-title":"Vaccine"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/CVI.00162-06","article-title":"A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial","volume":"13","author":"Martin","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","article-title":"Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates","volume":"251","author":"Hevey","year":"1998","journal-title":"Virology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3201\/eid0805.010284","article-title":"Evaluation in nonhuman primates of vaccines against Ebola virus","volume":"8","author":"Geisbert","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Olinger, G.G., and Hart, M.K. (2006). Protective Immunity to Ebola Infection by Venezuelan Equine Encephalitis Virus Replicons Expressing Ebola Virus Proteins, An ICID Global Symposium.","DOI":"10.1128\/JVI.79.22.14189-14196.2005"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","article-title":"Chimpanzee adenovirus vaccine protects against Zaire Ebola virus","volume":"346","author":"Kobinger","year":"2006","journal-title":"Virology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.1086\/520603","article-title":"Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice","volume":"196","author":"Patel","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2006.05.033","article-title":"Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges","volume":"353","author":"Wang","year":"2006","journal-title":"Virology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.vaccine.2005.11.046","article-title":"De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1016\/j.vaccine.2004.01.063","article-title":"Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection","volume":"22","author":"Warfield","year":"2004","journal-title":"Vaccine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2008.09.020","article-title":"Protection against lethal challenge by Ebola virus-like particles produced in insect cells","volume":"383","author":"Sun","year":"2009","journal-title":"Virology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.virol.2008.09.030","article-title":"Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge","volume":"383","author":"Bukreyev","year":"2009","journal-title":"Virology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JVI.80.5.2267-2279.2006","article-title":"A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge","volume":"80","author":"Bukreyev","year":"2006","journal-title":"J. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2008.09.082","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses","volume":"26","author":"Geisbert","year":"2008","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1086\/520591","article-title":"Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever","volume":"196","author":"Jones","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1128\/JVI.00959-06","article-title":"Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine","volume":"80","author":"Geisbert","year":"2006","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: An efficacy assessment","volume":"367","author":"Geisbert","year":"2006","journal-title":"Lancet"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.00456-08","article-title":"Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates","volume":"82","author":"Geisbert","year":"2008","journal-title":"J. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0020-7519(03)00064-X","article-title":"Vaccine research efforts for filoviruses","volume":"33","author":"Hart","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/viro.1997.8883","article-title":"Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants","volume":"239","author":"Hevey","year":"1997","journal-title":"Virology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(80)92352-1","article-title":"Inactivated vaccine for Ebola virus efficacious in guineapig model","volume":"2","author":"Lupton","year":"1980","journal-title":"Lancet"},{"key":"ref_101","first-page":"82","article-title":"The evaluation in hamadryas baboons of the possibility for the specific prevention of Ebola fever","volume":"39","author":"Mikhailov","year":"1994","journal-title":"Vopr. Virusol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","article-title":"Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates","volume":"251","author":"Hevey","year":"1998","journal-title":"Virology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/viro.2001.1012","article-title":"Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins","volume":"286","author":"Wilson","year":"2001","journal-title":"Virology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","article-title":"Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus","volume":"19","author":"Pushko","year":"2000","journal-title":"Vaccine"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein","volume":"75","author":"Wilson","year":"2001","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.76.18.9176-9185.2002","article-title":"Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: Protection in mice requires CD4(+) T cells","volume":"76","author":"Rao","year":"2002","journal-title":"J. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm0198-037","article-title":"Immunization for Ebola virus infection","volume":"4","author":"Xu","year":"1998","journal-title":"Nat. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/viro.1998.9176","article-title":"DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge","volume":"246","author":"Vanderzanden","year":"1998","journal-title":"Virology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2003.09.016","article-title":"Identification of murine T-cell epitopes in Ebola virus nucleoprotein","volume":"318","author":"Simmons","year":"2004","journal-title":"Virology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"984241","DOI":"10.1155\/2011\/984241","article-title":"Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever","volume":"2011","author":"Warfield","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat. Med."},{"key":"ref_115","first-page":"257","article-title":"Attempts to develop a vaccine against Ebola fever","volume":"40","author":"Chupurnov","year":"1995","journal-title":"Vopr. Virusol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/514316","article-title":"Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model","volume":"179","author":"Huggins","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-3542(00)00066-8","article-title":"Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor","volume":"45","author":"Bray","year":"2000","journal-title":"Antivir. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1086\/520587","article-title":"Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates","volume":"196","author":"Jahrling","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1086\/514298","article-title":"Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee","volume":"179","author":"Mupapa","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jviromet.2007.02.004","article-title":"Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens","volume":"143","author":"Shahhosseini","year":"2007","journal-title":"J. Virol. Methods"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.vaccine.2006.09.076","article-title":"Protective efficacy of neutralizing antibodies against Ebola virus infection","volume":"25","author":"Takada","year":"2007","journal-title":"Vaccine"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/514292","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"179","author":"Bray","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1128\/JVI.75.10.4649-4654.2001","article-title":"Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication","volume":"75","author":"Gupta","year":"2001","journal-title":"J. Virol."},{"key":"ref_124","first-page":"135","article-title":"Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses","volume":"11","author":"Jahrling","year":"1996","journal-title":"Arch. Virol. Suppl."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1128\/JVI.76.12.6408-6412.2002","article-title":"Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody","volume":"76","author":"Parren","year":"2002","journal-title":"J. Virol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/AAC.00936-08","article-title":"Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection","volume":"53","author":"Swenson","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_129","first-page":"93","article-title":"Antisense treatments for biothreat agents","volume":"8","author":"Warfield","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/504267","article-title":"Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference","volume":"193","author":"Geisbert","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study","volume":"375","author":"Geisbert","year":"2010","journal-title":"Lancet"},{"key":"ref_132","first-page":"87","article-title":"FGI-104: A broad-spectrum small molecule inhibitor of viral infection","volume":"1","author":"Kinch","year":"2009","journal-title":"Am. J. Transl. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1128\/AAC.01315-09","article-title":"Antiviral activity of a small-molecule inhibitor of filovirus infection","volume":"54","author":"Warren","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.clim.2011.08.008","article-title":"Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies","volume":"141","author":"Qiu","year":"2011","journal-title":"Clin. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e1575","DOI":"10.1371\/journal.pntd.0001575","article-title":"Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection","volume":"6","author":"Qiu","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1086\/514294","article-title":"Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections","volume":"179","author":"Sergeyev","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0042-6822(03)00416-1","article-title":"Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes","volume":"314","author":"Hevey","year":"2003","journal-title":"Virology"},{"key":"ref_139","first-page":"270","article-title":"Development and study of the properties of immunoglobulin against Ebola fever","volume":"40","author":"Borisevich","year":"1995","journal-title":"Vopr. Virusol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/rmv.405","article-title":"Antibody-dependent enhancement of viral infection: Molecular mechanisms and in vivo implications","volume":"13","author":"Takada","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1128\/JVI.77.13.7539-7544.2003","article-title":"Antibody-dependent enhancement of Ebola virus infection","volume":"77","author":"Takada","year":"2003","journal-title":"J. Virol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e36192","DOI":"10.1371\/journal.pone.0036192","article-title":"Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of ebola hemorrhagic Fever","volume":"7","author":"Marzi","year":"2012","journal-title":"PLoS One"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"138ra181","DOI":"10.1126\/scitranslmed.3003876","article-title":"Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-3542(00)00066-8","article-title":"Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor","volume":"45","author":"Bray","year":"2000","journal-title":"Antivir. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-3542(02)00183-3","article-title":"Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus","volume":"58","author":"Barrientos","year":"2003","journal-title":"Antivir. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.antiviral.2009.06.001","article-title":"Development of a broad-spectrum antiviral with activity against Ebola virus","volume":"83","author":"Aman","year":"2009","journal-title":"Antivir. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2007.12.008","article-title":"Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses","volume":"78","author":"Spurgers","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.2202","article-title":"Advanced antisense therapies for postexposure protection against lethal filovirus infections","volume":"16","author":"Warren","year":"2010","journal-title":"Nat. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1128\/AAC.50.3.984-993.2006","article-title":"VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice","volume":"50","author":"Enterlein","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_150","first-page":"51","article-title":"Microscopic study of species specific features of hemostatic impairment in Ebola virus infected monkeys","volume":"3","author":"Riabchikova","year":"1998","journal-title":"Vestn. Ross. Akad. Med. Nauk."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1086\/514293","article-title":"An analysis of features of pathogenesis in two animal models of Ebola virus infection","volume":"179","author":"Ryabchikova","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF02445023","article-title":"Experimental study of Ebola hemorrhagic fever in baboon models","volume":"120","author":"Luchko","year":"1995","journal-title":"Biull. Eksp. Biol. Med."},{"key":"ref_153","first-page":"113","article-title":"Experimental Ebola fever in Macaca mulatta","volume":"40","author":"Sergeev","year":"1995","journal-title":"Vopr. Virusol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.1711250303","article-title":"The pathology of experimental Ebola virus infection in monkeys","volume":"125","author":"Baskerville","year":"1978","journal-title":"J. Pathol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2011.08.022","article-title":"A small nonhuman primate model for filovirus-induced disease","volume":"420","author":"Carrion","year":"2011","journal-title":"Virology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/166.4.753","article-title":"Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain","volume":"166","author":"Brammer","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.micinf.2011.05.002","article-title":"Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: Differences in disease course and clinical pathology","volume":"13","author":"Reed","year":"2011","journal-title":"Microbes Infect."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0140-6736(90)90737-P","article-title":"Preliminary report: Isolation of Ebola virus from monkeys imported to USA","volume":"335","author":"Jahrling","year":"1990","journal-title":"Lancet"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1086\/514305","article-title":"Pathogenesis of experimental Ebola virus infection in guinea pigs","volume":"179","author":"Connolly","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"S1090","DOI":"10.1093\/infdis\/jir379","article-title":"Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection","volume":"204","author":"Tsuda","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1128\/JVI.79.22.14189-14196.2005","article-title":"Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins","volume":"79","author":"Olinger","year":"2005","journal-title":"J. Virol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.01097-07","article-title":"Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1","volume":"81","author":"Reid","year":"2007","journal-title":"J. Virol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/JVI.02575-10","article-title":"Marburg virus VP40 antagonizes interferon signaling in a species-specific manner","volume":"85","author":"Valmas","year":"2011","journal-title":"J. Virol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.antiviral.2012.01.011","article-title":"The role of antigen-presenting cells in filoviral hemorrhagic fever: Gaps in current knowledge","volume":"93","author":"Martinez","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_166","first-page":"25","article-title":"Humanized SCID mouse models for biomedical research","volume":"324","author":"Pearson","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/4\/9\/1477\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:52:14Z","timestamp":1760219534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/4\/9\/1477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,7]]},"references-count":166,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,9]]}},"alternative-id":["v4091477"],"URL":"https:\/\/doi.org\/10.3390\/v4091477","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,7]]}}}